(2021) Treatment of hepatitis C virus infection with direct-acting antiviral agent-based regimens in Iranian patients with hereditary bleeding disorders. Virology Journal. p. 10.

(2020) Real-life efficacy of generic sofosbuvir/ledipasvir for treatment of Iranian patients with chronic hepatitis C: A cohort study. Caspian Journal of Internal Medicine. pp. 41-46. ISSN 2008-6164

(2019) Acute changes in cardiac function by direct acting antiviral therapy for hepatitis C-infected patients with thalassemia. Journal of Medical Virology. pp. 419-427. ISSN 0146-6615

(2019) First Report of Prevalence of Blood-Borne Viruses (HBV, HCV, HIV, HTLV-1 and Parvovirus B19) Among Hemophilia Patients in Afghanistan. Scientific Reports. p. 6. ISSN 2045-2322

(2019) Sofosbuvir and Ribavirin with or Without Pegylated-Interferon in Hepatitis C Virus Genotype-2 or -3 Infections: A Systematic Review and Meta-Analysis. Archives of Clinical Infectious Diseases. p. 10. ISSN 2345-2641

(2018) Detection of Occult Hepatitis B Virus Among Iranian HCV-Infected Patients with Hemophilia Treated with Direct-Acting Antiviral Agents. Hepatitis Monthly. p. 6. ISSN 1735-143X

(2018) A facile PCR-RFLP method for genotyping of ITPA rs1127354 and rs7270101 polymorphisms. Journal of Clinical Laboratory Analysis. p. 6. ISSN 0887-8013

(2017) Assessment of Hepatitis C Virus RNA in Peripheral Blood Mononuclear Cells as a Predictor of Response to Pegylated-Interferon and Ribavirin: A Cohort Study. Iranian Red Crescent Medical Journal. p. 7. ISSN 2074-1804

(2017) Cardiac effects of Ledipasvir plus sofosbuvir for Hepatitis C treatment in thalassemia: PS067. Porto Biomed J. pp. 191-192. ISSN 2444-8664

(2017) Combination of Ledipasvir and Sofosbuvir for Treatment of Hepatitis C Virus Genotype 1 Infection: Systematic Review and Meta-Analysis. Annals of Hepatology. pp. 188-197. ISSN 1665-2681

(2017) Combination of sofosbuvir, pegylated-interferon and ribavirin for treatment of hepatitis C virus genotype 1 infection: a systematic review and meta-analysis. Daru-Journal of Pharmaceutical Sciences. p. 8.

(2017) Efficacy and Safety of Generic Sofosbuvir/Ledipasvir Fixed-Dose Combination in Iranian Patients with Chronic Hepatitis C Virus Infection. Hepatitis Monthly. p. 5. ISSN 1735-143X

(2017) Impact of IFNL4 rs12979860 and rs8099917 polymorphisms on response to Peg-Interferon-alpha and Ribavirin in patients with congenital bleeding disorder and chronic hepatitis C. Journal of Clinical Laboratory Analysis. p. 8. ISSN 0887-8013

(2017) The Role of Polymorphisms Near IFNL3 Gene as Predictors of Residual HCV RNA in Buffy Coat after Successful Antiviral Therapy. Hepatitis Monthly. p. 6. ISSN 1735-143X

(2017) A Simple PCR-RFLP Method for Genotyping of IFNL4 rs368234815 Polymorphism in Patients With Chronic Hepatitis C. Laboratory Medicine. pp. 51-56. ISSN 0007-5027

(2016) The ITPA and C20orf194 Polymorphisms and Hematological Changes During Treatment With Pegylated-Interferon Plus Ribavirin in Patients With Chronic Hepatitis C. Hepatitis Monthly. p. 9. ISSN 1735-143X

(2016) Next Steps Toward Eradication of Hepatitis C in the Era of Direct Acting Antivirals. Hepatitis Monthly. p. 6. ISSN 1735-143X

(2016) The Prevalence of Hepatitis C Virus Core Amino Acid 70 Substitution and Genotypes of Polymorphisms Near the IFNL3 Gene in Iranian Patients With Chronic Hepatitis C. Hepatitis Monthly. p. 11. ISSN 1735-143X

(2016) Recommendations for the Clinical Management of Hepatitis C in Iran: A Consensus-Based National Guideline. Hepatitis Monthly. p. 14. ISSN 1735-143X

(2016) The Role of Polymorphisms Near the IL28B Gene on Response to Peg-Interferon and Ribavirin in Thalassemic Patients With Hepatitis C. Hepatitis Monthly. p. 10. ISSN 1735-143X

(2016) Safety and Efficacy of Adding Ribavirin to Interferon or Peginterferon in Treatment of Hepatitis C Infection in Patients With Thalassemia: A Systematic Review on Randomized Controlled Trials. Hepatitis Monthly. p. 10. ISSN 1735-143X

(2016) The interferon lambda 4 rs368234815 predicts treatment response to pegylated-interferon alpha and ribavirin in hemophilic patients with chronic hepatitis C. Journal of Research in Medical Sciences. p. 4. ISSN 1735-1995

(2015) Efficacy of Prolonged Treatment With Pegylated Interferon (Peg-IFN) and Ribavirin in Thalassemic Patients With Hepatitis C Who Relapsed After Previous Peg-IFN-Based Therapy. Hepatitis Monthly. p. 5. ISSN 1735-143X

(2015) High Response Rate to Pegylated Interferon Alpha and Ribavirin Combination Therapy in Hemophilic Children with Chronic Hepatitis C; A Case-Control Study. Pediatric Hematology and Oncology. pp. 399-405. ISSN 0888-0018

(2014) Effect of zinc supplementation on viral response in patients with chronic hepatitis C and Beta thalassemia major, a pilot study. J Clin Diagn Res. Hc16-9. ISSN 2249-782X (Print) 0973-709x

(2014) Letter: the rs12979860 and ss469415590 polymorphisms of IFNL4 gene are in strong linkage disequilibrium in Caucasian patients with chronic hepatitis C. Alimentary Pharmacology & Therapeutics. p. 343. ISSN 0269-2813

(2014) Mysterious Linkages Between Hepatitis C Virus Genotypes, Interleukin-28B Genotypes and Viral Clearance-A Meta-Analysis. Hepatitis Monthly. p. 8. ISSN 1735-143X

(2013) Cost-Effectiveness Analysis of Adding Low Dose Ribavirin to Peginterferon Alfa-2a for Treatment of Chronic Hepatitis C Infected Thalassemia Major Patients in Iran. Hepatitis Monthly. p. 8. ISSN 1735-143X

(2013) Impact of Pegylated Interferon-alfa-2a on Perforin Level in Patients With Chronic Hepatitis B; Preliminary Study. Hepatitis Monthly. p. 5. ISSN 1735-143X

(2013) Plasma Zinc Level in Hepatitis C Patients With or Without Beta Thalassemia Major; Is There Any Difference? Hepatitis Monthly. p. 3. ISSN 1735-143X

(2013) The Seroprevalence of Entrically Transmitted Viral Hepatitis in HCV Infected Thalassemia and Hemophilia Patients in Iran. Jundishapur Journal of Microbiology. p. 6. ISSN 2008-3645

(2012) CORE AMINO ACID 70 SUBSTITUTION IN DIFFERENT HCV GENOTYPES AND ASSOCIATION WITH IL28B POLYMORPHISMS. Journal of Hepatology. S350-S350. ISSN 0168-8278

(2012) Development and Validation of a Simple, Rapid and Inexpensive PCR-RFLP Method for Genotyping of Common IL28B Polymorphisms: A Useful Pharmacogenetic Tool for Prediction of Hepatitis C Treatment Response. Hepatitis Monthly. pp. 190-195. ISSN 1735-143X

(2012) Distribution of IL28B Genotypes in Iranian Patients with Chronic Hepatitis C and Healthy Individuals. Hepatitis Monthly. p. 6. ISSN 1735-143X

(2012) EMERGENCE OF HBSAG ESCAPE MUTATIONS IS ASSOCIATED WITH USE OF NUCLEOS(T)IDE ANALOGUES IN CHRONIC HEPATITIS B PATIENTS. Journal of Hepatology. S197-S197. ISSN 0168-8278

(2012) Efficacy of Influenza Vaccination in Patients with Cirrhosis and Inactive Carriers of Hepatitis B Virus Infection. Iranian Red Crescent Medical Journal. pp. 623-630. ISSN 2074-1804

(2012) Impact of erythropoietin on sustained virological response to peginterferon and ribavirin therapy for HCV infection: a systematic review and meta-analysis. Journal of Viral Hepatitis. pp. 88-93. ISSN 1352-0504

(2012) Low Dose Ribavirin for Treatment of Hepatitis C Virus Infected Thalassemia Major Patients; New Indications for Combination Therapy. Hepatitis Monthly. pp. 372-381. ISSN 1735-143X

(2012) Real Response to Therapy in Chronic Hepatitis C Virus Patients: A Study From Iran. Hepatitis Monthly. p. 8. ISSN 1735-143X

(2012) Standard and pegylated interferon therapy of HDV infection: A systematic review and meta-analysis. Journal of Research in Medical Sciences. pp. 967-974. ISSN 1735-1995

(2011) IL28B SNP genotyping among Iranian HCV-infected patients: A preliminary report. Hepatitis Monthly. pp. 386-387. ISSN 1735-143X

(2011) Lipid Profiles and Hepatitis C Viral Markers in HCV-Infected Thalassemic Patients. Gut and Liver. pp. 348-355. ISSN 1976-2283

(2011) OPTIMAL DURATION OF ANTI-HCV THERAPY IN GENOTYPE-1 SLOW RESPONDERS WITH HIGH VIRAL LOAD; A SYSTEMATIC REVIEW AND META-ANALYSIS. Journal of Hepatology. S196-S196. ISSN 0168-8278

(2011) Optimal Duration of Treatment for HCV Genotype 1 Infection in Slow Responders: A Meta-Analysis. Hepatitis Monthly. pp. 612-619. ISSN 1735-143X

(2011) Reactivation of Brucellosis during pegylated interferon-alpha therapy in a thalassemic patient with chronic hepatitis C. Experimental and Clinical Hepatology. pp. 57-59. ISSN 17343038 (ISSN)

(2010) The Comparative Efficacy and Safety of Peginterferon Alpha-2a vs. 2b for the Treatment of Chronic HCV Infection: A Meta-Analysis. Hepatitis Monthly. pp. 121-131. ISSN 1735-143X

(2010) Comparative efficacy and overall safety of different doses of consensus interferon for treatment of chronic HCV infection: a systematic review and meta-analysis. European Journal of Clinical Pharmacology. pp. 1071-1079. ISSN 0031-6970

(2010) Distribution of Hepatitis C Virus Genotypes in Iranian Patients with Congenital Bleeding Disorders. Iranian Red Crescent Medical Journal. pp. 608-614. ISSN 2074-1804

(2010) Erythropoietin adjuvant therapy and sustained virological response in HCV-infected patients. Alimentary Pharmacology & Therapeutics. pp. 509-510. ISSN 0269-2813

(2010) Peginterferon α-2a and ribavirin treatment of patientswith haemophilia and hepatitis C virus infection: A single-centre study of 367 cases. Liver International. pp. 1173-1180. ISSN 14783223 (ISSN)

(2010) SAFETY AND EFFICACY OF RIBAVIRIN FOR TREATMENT OF THALASSEMIC PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION; A CONTROLLED CLINICAL TRIAL OF 280 CASES. Journal of Hepatology. S28-S28. ISSN 0168-8278

(2010) A Woman with Recent Jaundice and Pruritus. Hepatitis Monthly. pp. 48-52. ISSN 1735-143X

(2009) Distribution of hepatitis C virus genotype in Iranian multiply transfused patients with thalassemia. Transfusion. pp. 2195-2199. ISSN 0041-1132

(2009) Hepatitis C levels and histological damages - Need more evidence and attention. Arab Journal of Gastroenterology. p. 112. ISSN 16871979 (ISSN)

(2007) Prevalence of cigarette smoking and smoking-related disease correlates in Iranian asymptomatic HBV carriers. Archives of Medical Science. pp. 240-244. ISSN 1734-1922

(2007) What is the reason for poor outcome of antepartum immunoprophylaxis of hepatitis B immunoglobulin in prevention of vertical hepatitis B transmission? Hepatitis Monthly. pp. 163-165. ISSN 1735-143X